BamSEC and AlphaSense Join Forces
Learn More

ProPhase Labs Inc. – Underwriting Agreements

OTC: PRPH    
Share price (7/7/26): $0.09    
Market cap (7/7/26): $1.259 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from 8-K 4 pages ProPhase Labs Initiates Potential Sale or Strategic Partnership of Be-Smart™ and Advances Crown Medical Collections Initiative Each Initiative Has the Potential to Drive Significant Liquidity and Strengthen the Company’s Balance Sheet
12/34/56
EX-1.1
from 8-K ~1 page Join Prophase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd to Register for the Free Webinar, Please Visit: HTTPS://WWW.REDCHIP.COM/WEBINAR/PRPH/89160870488 Questions Can Be Pre-Submitted to Prph@redchip.com or Online During the Live Event. About ProPhase Labs Inc
12/34/56
EX-1.1
from 8-K 3 pages ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture According to Crown Medical
12/34/56
EX-1.3
from 8-K 19 pages Common Stock Purchase Warrant ProPhase Labs Inc
12/34/56
EX-1.2
from 8-K 3 pages Exhibit D: Irrevocable Instructions
12/34/56
EX-1.1
from 8-K 1 page Prophase Labs Uplists From Pink Sheets to Otc Market About ProPhase Labs Inc
12/34/56
EX-1.1
from 8-K 37 pages The Placement Agent for This Stock Purchase Agreement Is Enclave Capital LLC, a Broker - Dealer Registered With the U.S. Securities and Exchange Commission and Is a Member of Finra Stock Purchase Agreement
12/34/56
EX-1.1
from 8-K 2 pages ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value
12/34/56
EX-1.1
from 424B5 31 pages $4,265,221 Common Stock Sales Agreement
12/34/56
EX-1.1
from 424B5 31 pages $4,265,221 Common Stock Sales Agreement
12/34/56
EX-1.1
from 8-K 3 pages ProPhase Labs Signs Non-Binding Loi for Proposed Reverse Merger With Advanced Biological Laboratories Proposed Transaction Aims to Deliver Near-Term Value for Prophase Shareholders, Long-Term Growth for Abl, and Create a Global, Innovation-Driven Company. Company to Hold a Virtual Conference Call Today at 10:00 A.M. Et
12/34/56
EX-1
from 8-K/A 2 pages Underwriting agreement
12/34/56
EX-1
from 8-K/A 2 pages Underwriting agreement
12/34/56
EX-1
from DEF 14A 2 pages Underwriting agreement
12/34/56
EX-1
from PRE 14A 2 pages Underwriting agreement
12/34/56
EX-1.1
from 8-K 31 pages $4,265,221 Common Stock Sales Agreement
12/34/56
EX-1.1
from 424B5 31 pages $4,265,221 Common Stock Sales Agreement
12/34/56
EX-1
from DEF 14A 2 pages Underwriting agreement
12/34/56
EX-1
from PRER14A 2 pages Underwriting agreement
12/34/56
EX-1
from PRE 14A 2 pages Underwriting agreement
12/34/56